Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China

This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Junting Yang, Sarah Welby, Zhike Liu, Siwei Deng, Guangxu Liu, Ruogu Meng, Yu Yang, Yixin Sun, Yunkun He, Ning Jiang, Zhenhua Wu, Keruo Liu, Dominique Rosillon, Catherine Cohet, Siyan Zhan
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Taylor & Francis Group 2024-12-01
Reeks:	Human Vaccines & Immunotherapeutics
Onderwerpen:	HPV-16/18-AS04 human papillomavirus vaccine safety potential immune-mediated diseases pregnancy outcomes
Online toegang:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!